Volkswagen’s Potential Exit Throws Rafael’s German Weapons Factory Into Uncertainty
Rafael’s plan to build missiles in Germany hits a snag as Volkswagen reconsiders selling its Wolfsburg plant to the Israeli defense giant.
Rafael’s plan to build missiles in Germany hits a snag as Volkswagen reconsiders selling its Wolfsburg plant to the Israeli defense giant.
A wave of tech exits is channeling hundreds of millions into local nonprofits, reshaping how startup wealth flows back into communities.
Cellebrite is attending multiple investor conferences in September 2025, signaling continued engagement with Wall Street as its digital intelligence platform grows.
XCOTTON takes the IFA 2026 stage to reframe retail tech around trust, identity, and post-checkout consumer relationships.
Apple may skip the iPhone 18 branding altogether in 2026, reshaping upgrade cycles and consumer expectations heading into a big product year.
ColPlant acquires LightSolver, pivoting into photonic computing with laser-based AI hardware that outpaces GPUs on certain workloads.
Pure Global’s 2026 analysis of 15 national medical device registration databases exposes structural flaws that skew compliance and market decisions.
Wissen Research projects the anti-aging drugs market will hit $102.5 billion by 2031, driven by senolytics, NAD+ boosters, and an aging global population.
Oura is filing for an IPO, but Ultrahuman, RingConn, and others are building serious competition in the fast-growing smart ring market.
The global biosimilars market is projected to hit $70.79 billion by 2036, driven by patent expirations and rising demand for affordable biologics.